Phase I - Pharmacokinetic Comparability Study in Healthy Male Volunteers
Status:
Unknown status
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
Double-blind, single-dose, three-treatment, parallel group design PK comparability study of
MYL-1402O solution manufactured for Mylan compared to US and EU marketed Avastin® solution
(bevacizumab).